STRESS DEGRADATION STUDIES OF DRONEDARONE IN PHARMACEUTICAL DOSAGE FORM BY A VALIDATED STABILITY-INDICATING LC METHOD

被引:7
作者
Ahirrao, V. K. [1 ]
Patil, C. S. [1 ]
Bembalkar, S. R. [1 ]
Katariya, M. V. [1 ]
Sonnekar, V. S. [1 ]
Marathe, R. P. [2 ]
Nawale, R. B. [2 ]
Pawar, R. P. [1 ]
机构
[1] Deogiri Coll, Dept Chem, Aurangabad 431004, MS, India
[2] Govt Coll Pharm Aurangabad, Aurangabad 431004, MS, India
关键词
Liquid chromatography; Method validation; Pharmaceutical preparation; Dronedarone hydrochloride; Stress degradation; ATRIAL-FIBRILLATION; FLUTTER;
D O I
10.4067/S0717-97072012000300016
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A simple, rapid, and precise method is developed for the quantitative estimation of dronedarone hydrochloride in presence of its degradants which are formed due to stress conditions. A chromatographic separation of the dronedarone and its degradants were achieved with Zorbax XDB C-8 150 x 4.6 mm, 3.5 mu m analytical column using aqueous solution of 0.05M ammonium acetate and acetonitrile (40:60 v/v). The instrumental settings are flow, rate of 1.0 mL/min, column temperature at 30 degrees C, and detector wavelength of 220 nm using a photodiode array detector. Observed theoretical plates and tailing factor for dronedarone were 6577 and 1.09 respectively. Dronedarone vi,as exposed to thermal, photolytic, hydrolytic and oxidative stress conditions, and the stressed samples were analysed by the proposed method. Peak homogeneity data of dronedarone is obtained using photodiode array detector. The stressed sample chromatograms demonstrate the specificity of the method for the estimation dronedarone in presence of its degradants. The described method showed excellent linearity over a range of 10 - 300 mu g/mL for dronedarone. The correlation coefficient is 0.999. The relative standard deviation of peak area for six measurements is always found to be less than 2%. The proposed method was found to be suitable and accurate for quantitative determination and stability study of dronedarone.
引用
收藏
页码:1272 / 1276
页数:5
相关论文
共 14 条
[1]  
[Anonymous], US Patent, Patent No. 7312345
[2]  
[Anonymous], PHOT TEST NEW DRUG S
[3]  
[Anonymous], 2003, STAB TEST NEW DRUG S
[4]  
Baertschi S., 2005, PHARM STRESS TESTING, P141
[5]   Development of validated stability-indicating assay methods - critical review [J].
Bakshi, M ;
Singh, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (06) :1011-1040
[6]   Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection [J].
Bolderman, Robert W. ;
Hermans, J. J. Rob ;
Maessen, Jos G. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (18-19) :1727-1731
[7]   Dronedarone: An amiodarone analog for the treatment of atrial fibrillation and atrial flutter [J].
Dale, Krista M. ;
White, C. Michael .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) :599-605
[8]   Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation [J].
Hohnloser, Stefan H. ;
Crijns, Harry J. G. M. ;
van Eickels, Martin ;
Gaudin, Christophe ;
Page, Richard L. ;
Torp-Pedersen, Christian ;
Connolly, Stuart J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (07) :668-678
[9]  
ICH, 1996, Harmonised Tripartite Guideline Guidance for Industry Q2B Validation of Analytical Procedures: Methodology
[10]   Increased mortality after dronedarone therapy for severe heart failure [J].
Kober, Lars ;
Torp-Pedersen, Christian ;
McMurray, John J. V. ;
Gotzsche, Ole ;
Levy, Samuel ;
Crijns, Harry ;
Amlie, Jan ;
Carlsen, Jan .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (25) :2678-2687